Manchester Financial Inc. Has $2.30 Million Holdings in HCA Healthcare, Inc. $HCA

Posted by Stanley Muller on Aug 29th, 2026

Manchester Financial Inc. increased its holdings in HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 26.5% in the second quarter, Holdings Channel reports. The institutional investor owned 5,900 shares of the company’s stock after buying an additional 1,235 shares during the period. HCA Healthcare makes up 0.4% of Manchester Financial Inc.’s holdings, making the stock its 26th largest holding. Manchester Financial Inc.’s holdings in HCA Healthcare were worth $2,300,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in HCA. Mufg Securities Americas Inc. raised its stake in HCA Healthcare by 8.0% in the second quarter. Mufg Securities Americas Inc. now owns 4,677 shares of the company’s stock valued at $1,824,000 after purchasing an additional 346 shares in the last quarter. Nissay Asset Management Corp Japan increased its holdings in HCA Healthcare by 1.5% in the 2nd quarter. Nissay Asset Management Corp Japan now owns 20,886 shares of the company’s stock valued at $8,143,000 after buying an additional 309 shares during the period. Wellington Management Group LLP lifted its holdings in shares of HCA Healthcare by 20.5% during the 2nd quarter. Wellington Management Group LLP now owns 4,707,473 shares of the company’s stock worth $1,835,397,000 after acquiring an additional 799,761 shares during the period. Archer Investment Corp bought a new position in HCA Healthcare in the second quarter valued at approximately $78,000. Finally, Kingsview Wealth Management LLC bought a new stake in HCA Healthcare during the second quarter worth $737,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Trading Down 0.4%

NYSE HCA opened at $417.57 on Friday. HCA Healthcare, Inc. has a 12 month low of $353.99 and a 12 month high of $556.52. The firm has a market capitalization of $90.40 billion, a PE ratio of 13.98, a price-to-earnings-growth ratio of 1.46 and a beta of 1.10. The business’s 50-day moving average price is $401.08 and its two-hundred day moving average price is $441.46.

HCA Healthcare (NYSE:HCA – Get Free Report) last announced its earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating the consensus estimate of $7.56 by $0.03. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business had revenue of $20.23 billion for the quarter, compared to analysts’ expectations of $19.76 billion. During the same period in the prior year, the business posted $6.84 earnings per share. The firm’s revenue was up 8.7% on a year-over-year basis. As a group, analysts forecast that HCA Healthcare, Inc. will post 29.42 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

Wall Street Analyst Weigh In

A number of research firms have recently commented on HCA. Cantor Fitzgerald lowered their price target on HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating for the company in a report on Tuesday, July 7th. Wells Fargo & Company lifted their target price on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a research report on Monday, August 3rd. Mizuho lowered their price target on shares of HCA Healthcare from $525.00 to $475.00 and set an “outperform” rating for the company in a report on Tuesday, July 28th. Royal Bank Of Canada restated an “outperform” rating and set a $435.00 price objective on shares of HCA Healthcare in a research report on Monday, July 27th. Finally, Jefferies Financial Group set a $450.00 target price on HCA Healthcare in a research report on Tuesday, July 14th. Fourteen investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $462.64.

View Our Latest Stock Report on HCA

About HCA Healthcare

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.